Table 3.
Recurrence prediction | Metastasis prediction | Overall survival prediction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients | Recurrences | Concordance index | SE | Patients | Distant metastasis | Concordance index | SE | Patients | Deaths | Concordance index | SE | |
Clinical parameters T-stage, N-stage, HPV-status, Smoking (PY) |
103 | 27 | 0.699 | 0.049 | 103 | 10 | 0.690 | 0.097 | 103 | 37 | 0.691 | 0.043 |
PET parameters SUVmax, SUVmean, SUVpeak, TLG, MATV |
103 | 27 | 0.616 | 0.065 | 103 | 10 | 0.759 | 0.062 | 103 | 37 | 0.711 | 0.041 |
Radiomics parameters Factor 1 to 8 | 103 | 27 | 0.716 | 0.055 | 103 | 10 | 0.746 | 0.079 | 103 | 37 | 0.714 | 0.05 |
Combined clinical + PET parameters | 103 | 27 | 0.758 | 0.05 | 103 | 10 | 0.822 | 0.047 | 103 | 37 | 0.744 | 0.042 |
Combined clinical + radiomics | 103 | 27 | 0.770 | 0.043 | 103 | 10 | 0.831 | 0.066 | 103 | 37 | 0.749 | 0.047 |
Combined clinical + PET + radiomics | 103 | 27 | 0.796 | 0.045 | 103 | 10 | 0.945 | 0.029 | 103 | 37 | 0.750 | 0.046 |